Search this site

Exec Summary: The proposed UnitedHealth Group EMIS merger is currently being investigated by the Competition and Markets Authority (CMA) in the UK. The CMA is a government agency that is responsible for investigating mergers and acquisitions to ensure that they do not harm competition. The CMA has until July 12, 2023 to make a decision on whether or not to approve the merger. There are a number of factors that could affect the CMA's decision. These factors include: The impact of the merger on competition: The CMA will consider whether the merger will reduce competition in the market for healthcare IT services. If the CMA believes that the merger will reduce competition, it is likely to block the merger. The impact of the merger on consumers: The CMA will also consider the impact of the merger on consumers. If the CMA believes that the merger will lead to higher prices or lower quality of service for consumers, it is likely to block the merger. The views of third parties: The CMA will also consider the views of third parties, such as patient groups, healthcare providers, and other businesses in the healthcare IT sector. If the CMA receives a lot of negative feedback from third parties, it is more likely to block the merger. Overall, it is too early to say how likely the UnitedHealth Group EMIS merger is to go ahead. The CMA's decision will depend on a number of factors, including the impact of the merger on competition and consumers. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital Background: In January 2023, UnitedHealth Group announced that it would acquire EMIS Group Plc for £1.2 billion. EMIS Group is a UK-based healthcare software company that provides a range of products and services to healthcare providers, including electronic health records (EHRs), patient management systems, and clinical decision support tools. UnitedHealth Group is a US-based healthcare company that provides a range of healthcare-related products and services, including health insurance, healthcare management, and health data analytics. The merger was met with opposition from some patient groups and healthcare providers, who argued that it would reduce competition and lead to higher prices. The Competition and Markets Authority (CMA) in the UK is currently investigating the merger to determine if it will reduce competition in the market for healthcare IT services. The CMA has until July 12, 2023 to make a decision on whether or not to approve the merger. Here are some of the key issues that the CMA is likely to consider when making its decision: The impact of the merger on competition: The CMA will consider whether the merger will reduce competition in the market for healthcare IT services. If the CMA believes that the merger will reduce competition, it is likely to block the merger. The impact of the merger on consumers: The CMA will also consider the impact of the merger on consumers. If the CMA believes that the merger will lead to higher prices or lower quality of service for consumers, it is likely to block the merger. The views of third parties: The CMA will also consider the views of third parties, such as patient groups, healthcare providers, and other businesses in the healthcare IT sector. If the CMA receives a lot of negative feedback from third parties, it is more likely to block the merger. UNITEDHEALTH / EMIS Merger Enquiry Timetable 5 October 2023 - Statutory deadline Late September 2023 - Publish final report Late August 2023 - Final deadline for all parties’ responses/submissions August 2023 - Consider possible remedies and response hearing(s), (if required) Early August 2023 - Notifying provisional findings and considering possible remedies Late July 2023 - Deadline for all parties’ responses/submissions before provisional findings July 2023 - Main party hearings; verifying information; considering provisional findings Mid-May 2023 - Publish issues statement April to May 2023 - Gathering info, issuing questionnaires, 3rd party hearings, and site visit 31 March 2023 - Merger reference made Arguments for and against the UnitedHealth Group EMIS merger: Arguments in favour of the merger: The merger would create a more comprehensive healthcare IT platform: UnitedHealth Group and EMIS are both major providers of healthcare IT solutions. The merger would combine their strengths and create a more comprehensive platform that could better serve the needs of healthcare providers and patients. The merger would allow UnitedHealth Group to expand its reach into the UK market: UnitedHealth Group is a major player in the US healthcare market. The merger would allow it to expand its reach into the UK market, which is a growing market for healthcare IT solutions. The merger would create jobs: The merger would create jobs in the UK. UnitedHealth Group has said that it plans to invest £1 billion in the UK over the next five years. This investment would help to create jobs in the healthcare IT sector and other sectors of the economy. Arguments against the merger: The merger would reduce competition: UnitedHealth Group is a large player in the healthcare industry. The merger would give it a larger market share in the healthcare IT sector. This could lead to higher prices and lower quality of service for consumers. The merger would give UnitedHealth Group too much power: UnitedHealth Group is already a large and powerful company. The merger would give it even more power. This could lead to concerns about patient privacy and data security. The merger would not be in the best interests of patients: The merger would be driven by profit, not by the needs of patients. This could lead to higher prices, lower quality of care, and less choice for patients. Overall, there are both pros and cons to the UnitedHealth Group EMIS merger. The CMA will need to weigh these factors carefully before making a decision on whether or not to approve the merger. 3 key factors in the CMA's decision on the UnitedHealth Group EMIS merger The impact of the merger on competition: The CMA will consider whether the merger will reduce competition in the market for healthcare IT services. This will depend on a number of factors, including the size and market share of the merging companies, the number of other competitors in the market, and the barriers to entry for new businesses. The impact of the merger on consumers: The CMA will also consider the impact of the merger on consumers. This will depend on a number of factors, including the prices of healthcare IT services, the quality of service, and the choice of providers available to consumers. The views of third parties: The CMA will also consider the views of third parties, such as patient groups, healthcare providers, and other businesses in the healthcare IT sector. These parties may provide evidence to the CMA about the potential impact of the merger on competition and consumers. Overall, the CMA's decision on the UnitedHealth Group EMIS merger will depend on a number of factors, including the impact of the merger on competition and consumers. The CMA is expected to make its decision by July 12, 2023. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital

Revised Exec Summary: 7th August 2023 Babylon/MindMaze merger proposed by AlbaCore Capital LLP has been called off, will no longer proceed as previously announced. Babylon is in discussions with a number of new parties looking at new strategic alternatives for its businesses in both the UK and US. Babylon is pursuing the divestiture of its UK business to third parties that may provide financing to assure the continuity of the operations. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital Press release stated ... "Babylon Holdings Limited (OTC Pink: BBLNF) (“Babylon”, and together with its subsidiaries, the “Group”) today announced that the transaction proposed by AlbaCore Capital LLP (“AlbaCore”) and MindMaze Group SA (“MindMaze”), for a business combination of Babylon’s core operating subsidiaries with MindMaze, previously announced on June 23, 2023 (the “Previously Proposed Transaction”), will not proceed. Following Babylon’s receipt of funding under its amended bridge notes facility with AlbaCore, Babylon has no binding commitment for additional financing to continue its business operations. As a result, the Group is exploring new strategic alternatives in order to find the best possible outcome for its UK business. Babylon remains focused on continuing the day to day operations of its UK business, providing accessibility of its healthcare services and the highest standards of care for its patients and members. The Group is pursuing the divestiture of its UK business to third parties that may provide financing to assure the continuity of the operations. Babylon has built a successful, distinct and sustainable UK business which provides high quality healthcare to many. However, it cannot provide assurance that any of these initiatives will result in Babylon entering into a definitive agreement for or completing a divestiture. Further, Babylon is exiting its core US business and plans to safely transition its US members to other providers, and continues to pursue its previously disclosed process for the sale of the Meritage Medical Network independent physicians association business (the “IPA Business”, and the sale of the IPA Business, the UK business or another particular business of Babylon is referred to as a “Third Party Sale”). In order to explore these opportunities for a Third Party Sale and enable business continuity, Babylon is in discussions with potential strategic partners to secure additional funding. Babylon cannot provide assurance that it will be able to secure sufficient liquidity to fund the operations of the Group’s businesses. To the extent that Babylon is unable to secure additional financing and complete a Third Party Sale of a particular business, the applicable entities of the Group will file for bankruptcy protection or implement other alternatives for an orderly wind down and liquidation or dissolution, which may include commencing Chapter 7 proceedings under the U.S. Bankruptcy Code and/or a UK administration for the applicable entities of the Group in the near term. Any Third Party Sale will be subject to AlbaCore’s rights under its debt agreements with Babylon, and the aggregate proceeds of any Third Party Sales are not expected to exceed the total amount of the Group’s indebtedness to AlbaCore. As a result, any such transaction will not provide for any payment to Babylon’s Class A ordinary shareholders and other equity instrument holders." Source: https://www.businesswire.com/news/home/20230806277244/en/Babylon-In-Discussions-of-New-Strategic-Alternatives-for-its-Businesses Exec Summary: June 23rd 2023 Babylon Holdings Limited (NYSE: BBLN) has agreed to the recapitalisation and take private proposal from AlbaCore Capital LLP which will result in a merger with Swiss based MindMaze Group SA. In combination with MindMaze, a global leader in brain technology and digital neurotherapeutic solutions for brain health and recovery, the new entity is positioned to uniquely address patient and member needs across the continuum-of-care, from healthcare through sick care. Babylon and MindMaze believe that the combined entity will form a powerful digital-first global AI-driven healthcare business that will help transform the industry from sick care to predictive and preventative healthcare. Babylon and MindMaze will be dedicated to improving patient engagement and access to high quality optimized healthcare by tackling a broad range of chronic conditions, including but not limited to neurological conditions. Babylon and its management will continue to operate and deliver on its existing business plan. Over the mid-to-long term Babylon and MindMaze intend to align the strengths of their organisations to deliver a truly novel care paradigm and deliver exceptional outcomes for all stakeholders. The transaction is expected to close in July 2023 and will not provide for any payment to Babylon Holdings Limited’s Class A ordinary shareholders or other equity instrument holders, as AlbaCore will be exercising rights under its debt agreements with Babylon, and the go-forward private business will be transferred to private ownership. Therefore, the transaction would transfer core operating subsidiaries of Babylon to MindMaze, and Babylon Holdings Limited’s Class A ordinary shares will cease trading on the NYSE under the ticker symbol ‘BBLN’. Sources: https://www.businesswire.com/news/home/20230623670219/en/Babylon-Announces-Update-on-Take-Private-Proposal Engage with the HealthTech Community Thoughts, comments? Tweet @lloydgprice, or email lloyd@healthcare.digital and let's start a conversation :) HealthTech M&A Newsletter - Join our community and subscribe today! https://www.linkedin.com/newsletters/7071223775639281664/ AlbaCore Capital Group AlbaCore Capital Group is a European investment firm and bespoke solutions provider, focusing on private debt and opportunistic credit investments. The firm was founded in 2016 by David Allen, Bill Ammons, and Deborah Cohen Malka, who previously worked together in the Canada Pension Plan Investment Board's Principal Credit Investments business in London. AlbaCore's core investment team has over 30 years of experience in the credit markets, and the firm has a track record of investing in and managing a wide range of credit strategies, including direct lending, collateralized loan obligations (CLOs), and distressed debt. The firm has offices in London, Dublin, and New York, and manages over $19 billion in assets. AlbaCore's clients include institutional investors, family offices, and high-net-worth individuals. The firm's investment philosophy is to focus on the long term and to build relationships with its portfolio companies. AlbaCore seeks to invest in companies that have strong management teams, sustainable business models, and the potential for growth. The firm's recent investments include Babylon Health, MindMaze, and Just Eat Takeaway.com. AlbaCore has also been active in the CLO market, and has priced five CLOs since 2017. AlbaCore is a leading alternative investment manager in Europe, and its track record and investment philosophy have attracted a strong following from institutional investors. The firm is well-positioned to continue to grow in the years to come. Here are some of the key facts about AlbaCore Capital Group: Founded in 2016 Headquarters in London Offices in Dublin and New York Over $19 billion in assets under management Investment focus: private debt and opportunistic credit Investment philosophy: long-term oriented, relationship-driven Recent investments: Babylon Health, MindMaze, Just Eat Takeaway.com Track record: consistently outperformed the market in the long term MindMaze MindMaze is a global leader in the development of AI-driven digital neurotherapeutics. The company's mission is to "empower people to recover and improve their brain function through innovative technologies." MindMaze's technology platform combines virtual reality, brain-computer interfaces, and artificial intelligence to create personalised, immersive, and engaging experiences that help patients recover from neurological injuries and diseases. The company's products are used by patients, clinicians, and researchers in over 100 countries around the world. Some of MindMaze's most notable products include: Muse: A brain-computer interface headband that helps users improve their focus, attention, and relaxation. Infinity: A virtual reality platform that helps patients with stroke, Parkinson's disease, and other neurological conditions regain motor function. Izar: A smart peripheral that helps patients with hand dexterity impairment improve their hand function. MindMaze's technology has been shown to be effective in a number of clinical trials. For example, a study published in the journal Neurology found that patients with stroke who used MindMaze's Infinity platform for 6 weeks showed significant improvements in their motor function. MindMaze is a privately held company headquartered in Lausanne, Switzerland. The company was founded in 2012 by Tej Thakur, Jaggi Sidhu, and Dr. Gerwin Schalk. MindMaze has raised over $100 million in funding from investors such as SoftBank Vision Fund, Fidelity Investments, and Robert Bosch Venture Capital. MindMaze is a rapidly growing company with a bright future. The company's technology has the potential to revolutionize the way we treat neurological injuries and diseases. With continued investment and development, MindMaze could become one of the leading players in the digital health industry. Here are some of the key benefits of MindMaze's AI-driven digital neurotherapeutics: Personalized: The company's technology is personalized to each individual patient, based on their specific needs and goals. Immersive: The company's products use virtual reality and other immersive technologies to create a more engaging and effective therapy experience. Engaging: The company's products are designed to be engaging and motivating, which helps patients stay motivated to continue with their therapy. Effective: The company's technology has been shown to be effective in a number of clinical trials. Background to the merger: VR, clinical trials and stroke patients Babylon Health and MindMaze are two leading companies in the digital health space. Babylon Health is a telemedicine company that provides users with access to healthcare professionals through a mobile app. MindMaze is a company that develops AI-driven digital neurotherapeutics. The two companies have partnered to develop a new product called Babylon MindMaze. This product combines Babylon Health's telemedicine platform with MindMaze's AI-driven neurotherapeutics to provide patients with a more personalized and effective way to manage neurological conditions. Babylon MindMaze is currently being used in a clinical trial in the United Kingdom. The trial is evaluating the effectiveness of the product in treating patients with stroke. The results of the trial are expected to be released in 2023. If the trial is successful, Babylon MindMaze could have a significant impact on the way we treat neurological conditions. The product could help patients recover more quickly and effectively from stroke and other neurological injuries and diseases. Here are some of the key benefits of the Babylon MindMaze partnership: Personalized: The product is personalized to each individual patient, based on their specific needs and goals. Immersive: The product uses virtual reality and other immersive technologies to create a more engaging and effective therapy experience. Engaging: The product is designed to be engaging and motivating, which helps patients stay motivated to continue with their therapy. Effective: The product is based on MindMaze's AI-driven neurotherapeutics, which have been shown to be effective in clinical trials. Looking to the future, the next chapter for Babylon The future of Babylon Health and MindMaze clinical trials is bright. The two companies are working on a number of promising projects that have the potential to revolutionize the way we treat neurological conditions. One of the most exciting projects is the development of a digital rehabilitation platform for patients with stroke. The platform combines Babylon Health's clinical expertise with MindMaze's AI-driven technology to create a personalized and immersive rehabilitation experience. The platform is still in development, but it has the potential to revolutionize the way stroke patients are treated. By combining clinical expertise with AI-driven technology, the platform can provide patients with a more effective and engaging rehabilitation experience. Another promising project is the development of a digital platform for patients with Parkinson's disease. This platform will use MindMaze's AI-driven technology to help patients improve their motor function. The Babylon Health and MindMaze clinical trials are still in the early stages, but they have the potential to make a significant impact on the lives of patients with neurological conditions. The two companies are working hard to develop these platforms and bring them to market. Here are some of the key factors that could influence the future of Babylon Health and MindMaze clinical trials: The success of the current clinical trials. If the trials are successful, it will provide strong evidence that the platforms are effective and safe. This will make it more likely that the platforms will be approved for use by regulatory agencies. The development of new AI-driven technologies. As AI-driven technologies continue to develop, they could be used to improve the effectiveness and efficiency of the platforms. This could make the platforms more attractive to patients and healthcare providers. The growth of the digital health market. The digital health market is growing rapidly, and this could create a larger market for the platforms. This could make it more feasible for Babylon Health and MindMaze to develop and market the platforms. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital

Exec Summary: There have been 49 healthcare cybersecurity M&A deals this year as of June 18, 2023. This number is up from 45 deals in 2022. The most active acquirers in the healthcare cybersecurity M&A space in 2023 have been Symphony Technology Group (10 deals), Thoma Bravo (7 deals), and Insight Partners (6 deals). The reasons for healthcare cybersecurity M&A deals in 2023 include: To expand product and service offerings. M&A deals can help companies expand their product and service offerings by acquiring companies with complementary technologies or capabilities. To enter new markets. M&A deals can help companies enter new markets by acquiring companies with a presence in those markets. To achieve economies of scale. M&A deals can help companies achieve economies of scale by combining their operations and resources. To reduce competition. M&A deals can help companies reduce competition by acquiring their competitors. The healthcare cybersecurity M&A landscape is expected to remain active in 2023 and beyond. As the healthcare industry continues to face increasing cybersecurity threats, healthcare organizations are increasingly looking to M&A as a way to improve their cybersecurity posture. Key M&A Themes The rise of managed security services providers (MSSPs). MSSPs are companies that provide a range of cybersecurity services to healthcare organizations, such as threat detection and response, vulnerability management, and incident response. The demand for MSSPs is growing as healthcare organizations face increasing cybersecurity threats. As a result, we are likely to see more M&A activity in the MSSP space in the coming years. The convergence of IT and OT security. IT and OT (operational technology) security are becoming increasingly converged, as healthcare organizations rely on more and more connected devices. This convergence is creating new challenges for healthcare organizations, as they need to protect both their IT and OT networks from cyberattacks. As a result, we are likely to see more M&A activity in the OT security space in the coming years. The increasing focus on data privacy and security. The healthcare industry is subject to a wide range of data privacy and security regulations, such as HIPAA and GDPR. As these regulations become more stringent, healthcare organizations are increasingly looking for ways to improve their data privacy and security posture. As a result, we are likely to see more M&A activity in the data privacy and security space in the coming years. The growing importance of artificial intelligence (AI). AI is increasingly being used in healthcare cybersecurity to automate tasks, detect threats, and respond to incidents. AI-powered solutions can help healthcare organizations to improve their security posture and reduce the risk of cyberattacks. As a result, we are likely to see more M&A activity in the AI cybersecurity space in the coming years. The need for integrated solutions. Healthcare organizations need cybersecurity solutions that can protect their entire environment, including their IT, OT, and cloud networks. Integrated solutions can help healthcare organizations to improve their security posture and reduce the risk of cyberattacks. As a result, we are likely to see more M&A activity in the integrated cybersecurity solutions space in the coming years. Future Trends The increasing sophistication of cyberattacks. Cyberattacks are becoming increasingly sophisticated, as attackers are using more advanced techniques to exploit vulnerabilities in healthcare organizations' systems. As a result, healthcare organizations need to be constantly vigilant and invest in cutting-edge cybersecurity solutions. The growing importance of cloud security. Healthcare organizations are increasingly moving their data and applications to the cloud. This shift has created new cybersecurity challenges, as cloud environments are more complex and difficult to secure. As a result, healthcare organizations need to have a strong cloud security strategy in place. The increasing regulation of healthcare cybersecurity. Governments around the world are increasingly regulating healthcare cybersecurity. This regulation is designed to protect patients' data and ensure that healthcare organizations are taking appropriate steps to protect their systems from cyberattacks. As a result, healthcare organizations need to be aware of the latest regulations and make sure that they are compliant. These are just some of the key M&A themes and future trends in healthcare cybersecurity. As the healthcare industry continues to evolve, it is likely that these trends will continue to develop. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital Healthcare Cyber Security: Healthcare cybersecurity is the practice of protecting sensitive patient data and healthcare information systems from unauthorised access, use, disclosure, disruption, modification, or destruction. Healthcare organisations are increasingly targeted by cyberattacks, as they hold some of the most valuable and sensitive data in the world. The goals of healthcare cybersecurity are to: Protect the confidentiality of patient data. This means ensuring that only authorized individuals can access patient data. Protect the integrity of patient data. This means ensuring that patient data is not modified or tampered with. Protect the availability of patient data. This means ensuring that patient data is accessible when it is needed. Healthcare organisations can implement a number of measures to improve their cybersecurity posture, including: Implementing strong security controls, such as firewalls, intrusion detection systems, and data encryption. Educating employees about cybersecurity risks and best practices. Conducting regular security assessments to identify and mitigate vulnerabilities. Responding promptly to security incidents. Healthcare cybersecurity is an ongoing process, as new threats emerge and evolve all the time. Healthcare organizations need to be constantly vigilant and take steps to protect their data and systems. Here are some of the specific challenges that healthcare organizations face in cybersecurity: The increasing use of connected devices in healthcare. These devices are often not as secure as traditional IT systems, making them more vulnerable to attack. The growing number of cyberattacks targeting healthcare organizations. These attacks are becoming more sophisticated and targeted, making them more difficult to defend against. The lack of awareness of cybersecurity risks among healthcare employees. This can lead to human errors that can be exploited by attackers. The complex regulatory environment governing healthcare data privacy and security. Healthcare organizations need to comply with a wide range of regulations, which can be a challenge. Despite these challenges, healthcare organizations can take steps to improve their cybersecurity posture. By implementing strong security controls, educating employees about cybersecurity risks, and conducting regular security assessments, healthcare organizations can help to protect their data and systems from attack. Key themes in healthcare cybersecurity M&A: Here are some specific examples of healthcare cybersecurity M&A deals that have taken place in recent years: In 2021, FireEye was acquired by Symphony Technology Group for $1.2 billion. FireEye is a leading provider of cybersecurity solutions, including AI-powered threat detection and response solutions. This acquisition demonstrates the growing interest in the healthcare cybersecurity market from both private equity firms and strategic buyers. In 2020, Tenable Network Security was acquired by Thoma Bravo for $5.7 billion. Tenable is a leading provider of vulnerability management solutions. This acquisition demonstrates the growing importance of vulnerability management in healthcare cybersecurity. In 2019, CrowdStrike was acquired by Symphony Technology Group for $1.1 billion. CrowdStrike is a leading provider of endpoint security solutions. This acquisition demonstrates the growing importance of endpoint security in healthcare cybersecurity. These deals demonstrate the growing interest in the healthcare cybersecurity market from both private equity firms and strategic buyers. As the healthcare industry continues to face increasing cybersecurity threats, it is likely that we will see more M&A activity in this space in the coming years. Future Trends: The healthcare cybersecurity landscape is constantly evolving, and there are a number of future trends that are likely to shape the M&A landscape in this space. The rise of managed security services providers (MSSPs). MSSPs are companies that provide a range of cybersecurity services to healthcare organizations, such as threat detection and response, vulnerability management, and incident response. The demand for MSSPs is growing as healthcare organizations face increasing cybersecurity threats. As a result, we are likely to see more M&A activity in the MSSP space in the coming years. The convergence of IT and OT security. IT and OT (operational technology) security are becoming increasingly converged, as healthcare organizations rely on more and more connected devices. This convergence is creating new challenges for healthcare organizations, as they need to protect both their IT and OT networks from cyberattacks. As a result, we are likely to see more M&A activity in the OT security space in the coming years. The increasing focus on data privacy and security. The healthcare industry is subject to a wide range of data privacy and security regulations, such as HIPAA and GDPR. As these regulations become more stringent, healthcare organizations are increasingly looking for ways to improve their data privacy and security posture. As a result, we are likely to see more M&A activity in the data privacy and security space in the coming years. The growing importance of artificial intelligence (AI). AI is increasingly being used in healthcare cybersecurity to automate tasks, detect threats, and respond to incidents. AI-powered solutions can help healthcare organizations to improve their security posture and reduce the risk of cyberattacks. As a result, we are likely to see more M&A activity in the AI cybersecurity space in the coming years. The need for integrated solutions. Healthcare organizations need cybersecurity solutions that can protect their entire environment, including their IT, OT, and cloud networks. Integrated solutions can help healthcare organizations to improve their security posture and reduce the risk of cyberattacks. As a result, we are likely to see more M&A activity in the integrated cybersecurity solutions space in the coming years. These are just some of the future trends that are likely to shape the M&A landscape in healthcare cybersecurity. As the healthcare industry continues to evolve, it is likely that these trends will continue to develop. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital

Exec Summary: The global healthtech M&A market is expected to remain active in 2023 and pick up pace in the spring/summer of 2024, driven by a range of macro/micro and additional factors: Continued economic recovery: The global economy is expected to continue to recover in 2024, which will boost investment in healthtech companies. Increased demand for value-based care: Healthcare payers are increasingly demanding value-based care, which is care that is delivered in a cost-effective and high-quality manner. Healthtech companies are developing innovative solutions to support value-based care, such as clinical decision support systems and population health management platforms. Increased focus on health equity: There is a growing focus on health equity in the healthcare industry, as governments and other stakeholders are increasingly recognizing the need to address the disparities in health outcomes that exist between different groups of people. Healthtech companies are developing innovative solutions to support health equity, such as social determinants of health platforms and telehealth solutions that target underserved populations. Based on these factors, the following are some predictions for healthtech M&A in 2024: Continued consolidation of the healthcare industry: As the healthcare industry continues to consolidate, larger healthcare companies are likely to acquire smaller healthtech companies in order to gain access to new technologies and markets. Increased investment from big tech companies: Big tech companies are likely to continue to invest in healthtech through acquisitions and partnerships. This is due to the fact that big tech companies see healthtech as a way to expand their reach into new markets and to capture new revenue streams. Focus on specific healthtech sectors: There are a number of specific healthtech sectors that are likely to see increased M&A activity in 2024, including: Telemedicine: Telemedicine is a rapidly growing sector that is attracting a lot of investment from both traditional healthcare companies and big tech companies. Mental health: The demand for mental health services is increasing, and healthtech companies are developing innovative solutions to support mental health care delivery. Digital therapeutics: Digital therapeutics are software-based solutions that are used to treat medical conditions. Digital therapeutics are a growing sector that is attracting a lot of investment from both traditional healthcare companies and big tech companies. Increased focus on value-based care and health equity: Healthcare payers and other stakeholders are increasingly demanding value-based care and health equity. Healthtech companies that develop solutions to support value-based care and health equity are likely to be attractive targets for M&A. Overall, the global healthtech M&A market is expected to remain active in 2024, driven by the growing demand for healthcare services, the increasing adoption of digital health technologies, the growing focus on preventive care, investment from big tech companies, and the continued economic recovery. In addition to the above predictions, it is also possible that we will see some mega-deals in the healthtech M&A market in 2024, as big tech companies look to make more significant investments in the healthcare sector. For example, we could see a big tech company acquire a large healthcare provider, or we could see a big tech company acquire a major healthtech company. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital Macro Healthtech M&A predictions in the next 12 months: More consolidation in the digital health space. As the digital health space continues to mature, we are likely to see more consolidation among companies. This will be driven by the need for scale, the need to access new markets, and the need to reduce competition. Big tech companies will continue to invest in healthtech. Big tech companies such as Amazon, Google, and Apple are already major players in the healthtech industry, and they are likely to continue to invest in this area in the next 12 months. This is because they see healthtech as a way to expand their reach into new markets and to capture new revenue streams. We will see more M&A activity in the area of preventive care. As the cost of healthcare continues to rise, there is a growing focus on preventive care. This means that companies that offer solutions that help people stay healthy will be in high demand. More investment in preventive care solutions. As the cost of healthcare continues to rise, there is a growing focus on preventive care. This means that companies that offer solutions that help people stay healthy will be in high demand. More innovation in the area of artificial intelligence (AI). AI is already being used in a number of healthcare applications, and this trend is likely to continue in the next 12 months. AI has the potential to revolutionize healthcare, and companies that are at the forefront of this innovation will be well-positioned for success. More deals involving startups. We are likely to see more deals involving startups in the next 12 months. This is because startups are often at the forefront of innovation, and they can offer big tech companies and other established players access to new technologies and markets. We will see more partnerships between healthtech companies and traditional healthcare providers. Healthtech companies are increasingly partnering with traditional healthcare providers to deliver care more efficiently and effectively. This includes partnerships between telehealth companies and hospitals, and between wearables companies and insurers. We will see more M&A activity in the area of virtual care. Virtual care is becoming increasingly popular, and we are likely to see more M&A activity in this area in the next 12 months. This is because virtual care offers a number of advantages, such as convenience, cost-effectiveness, and access to care. Micro Healthtech M&A predictions in the next 12 months Six specific examples of HealthTech M&A transactions that could happen in the next 6 to 12 months: A big tech company acquires a leading telehealth provider. This would allow the big tech company to expand its reach into the healthcare market and offer a more comprehensive suite of services to its customers. A pharmaceutical company acquires a leading digital health company. This would allow the pharmaceutical company to gain access to new technologies and data that could be used to develop new drugs and treatments. A health insurance company acquires a leading wearables company. This would allow the health insurance company to collect more data about its customers' health habits and use this data to tailor its products and services. Amazon could acquire a telehealth company. Amazon has been expanding its healthcare offerings in recent years, and it could look to acquire a telehealth company to further this expansion. Google could acquire a health data analytics company. Google has been investing heavily in health data analytics, and it could look to acquire a company that has a strong track record in this area. Apple could acquire a wearables company. Apple has been one of the leading players in the wearables market, and it could look to acquire a company that has a strong portfolio of wearable products. Potential surprises in healthtech M&A There are a number of potential surprises that could come in healthtech M&A in the coming 12 months. Here are a few examples: The failure of some healthtech companies. Some healthtech companies could fail in the coming years. This could lead to some M&A deals, as larger companies look to acquire the assets of these failed companies. The rise of new technologies. The healthcare industry is constantly evolving, and new technologies are emerging all the time. It is possible that one of these new technologies could disrupt the industry and lead to a wave of M&A activity. For example, the rise of artificial intelligence (AI) could lead to the acquisition of companies that are developing AI-powered healthcare solutions. The entry of new players into the market. The healthtech industry is becoming increasingly globalized, and new players are entering the market all the time. It is possible that one of these new players could make a surprise acquisition and shake up the industry. For example, a Chinese healthtech company could acquire a US-based company in a move to expand its global reach. The entry of new players into the healthtech M&A market. New players could enter the healthtech M&A market in the coming years. This could include private equity firms, venture capital firms, or even healthcare providers. These new players could bring new ideas and new approaches to the market, which could lead to some surprises. These are just a few examples of potential surprises that could come in healthtech M&A in the coming years. It will be interesting to see how the industry evolves and what kind of M&A activity we see in the years to come. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital

Exec Summary: there are a number of reasons why other European countries might consider adopting the German model. First, the German model has been successful in Germany. Since its launch in 2020, over 200 DiGAs have been approved, and over 50,000 patients have been prescribed DiGAs. This suggests that the German model has the potential to improve patient care and reduce costs in other European countries. Second, the German model is relatively fast and efficient. DiGAs can be approved in as little as three months, which makes it easier for developers to bring their products to market. This could help to accelerate the adoption of digital health technologies in other European countries. Third, the costs of DiGAs are covered by statutory health insurance in Germany. This makes DiGAs more affordable for patients, and it encourages doctors to prescribe them. This could also be a model for other European countries, as it could help to make digital health technologies more accessible to patients. Of course, there are also some challenges that other European countries would need to consider if they were to adopt the German model. These challenges include: The regulatory framework: The regulatory frameworks for digital health technologies vary from country to country. In order to adopt the German model, other European countries would need to ensure that their regulatory frameworks are compatible with the DiGA requirements. The availability of digital health technologies: The availability of digital health technologies also varies from country to country. In order to adopt the German model, other European countries would need to ensure that there is a sufficient number of DiGAs available that are relevant to their healthcare systems. Overall, there are both pros and cons to adopting the German model promoting digital health. Other European countries would need to carefully consider their own healthcare systems and regulatory frameworks before making a decision. However, the German model has the potential to improve patient care and reduce costs in other European countries, and it is a model that other countries could follow. Here are some of the countries that are considering adopting the German model: France Belgium Netherlands Denmark Sweden These countries are all looking at how the German model could be adapted to their own healthcare systems. It is likely that we will see more countries adopting the German model in the future, as digital health technologies become more widespread. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital Background to DiGA DiGA stands for "Digitale Gesundheitsanwendungen", which means "Digital Health Applications" in German. It is a new initiative in Germany that aims to promote the use of digital health technologies in the healthcare system. DiGAs are digital health applications that can be prescribed by doctors for patient use for a variety of diagnoses. They can be used to support the recognition, monitoring, treatment or alleviation of diseases or the recognition, treatment, alleviation or compensation of injuries or disabilities. DiGAs must meet a number of requirements in order to be approved for use in Germany. These requirements include: They must be CE-marked as Class 1 or 2a low risk medical devices. They must have been through a rigorous assessment process by the Federal Institute for Drugs and Medical Devices (BfArM). They must have been shown to be effective in clinical trials. They must be safe and secure. Once a DiGA is approved, it is added to a list of approved DiGAs (the "DiGA Directory"). Doctors can then prescribe DiGAs from the DiGA Directory to their patients. The costs of DiGAs are covered by statutory health insurance in Germany. The DiGA initiative is still in its early stages, but it has the potential to revolutionize the way healthcare is delivered in Germany. By making digital health technologies more accessible to patients and doctors, DiGAs can help to improve patient outcomes and reduce costs. Here are some of the benefits of the DiGA initiative: It can improve patient outcomes by providing patients with access to innovative digital health technologies that can help them to manage their conditions more effectively. It can reduce costs by making it easier for patients to access care and by providing doctors with tools that can help them to diagnose and treat patients more efficiently. It can improve the quality of care by making it easier for patients and doctors to communicate and collaborate. The DiGA initiative is a bold step forward for the German healthcare system. It has the potential to make healthcare more accessible, efficient, and effective for patients and doctors alike. Early success of DiGA The early success of German DiGA has been impressive. Since the first DiGAs were approved in October 2020, there have been over 200 DiGAs approved, and over 50,000 patients have been prescribed DiGAs. The most popular DiGAs are for mental health, chronic diseases, and weight management. There are a number of factors that have contributed to the early success of DiGAs. First, the DiGA initiative has been well-received by patients and doctors. Patients are eager to try new digital health technologies that can help them to manage their conditions more effectively. Doctors are also supportive of DiGAs, as they see them as a way to improve patient care and reduce costs. Second, the DiGA approval process is relatively fast and efficient. DiGAs can be approved in as little as three months, which makes it easier for developers to bring their products to market. Third, the costs of DiGAs are covered by statutory health insurance in Germany. This makes DiGAs more affordable for patients, and it encourages doctors to prescribe them. The early success of DiGA is a promising sign for the future of digital health in Germany. As more DiGAs are approved and more patients and doctors adopt them, DiGAs have the potential to revolutionize the way healthcare is delivered in Germany. Here are some of the challenges that DiGAs still face: Some doctors are still not familiar with DiGAs, and they may be hesitant to prescribe them. Some patients may be reluctant to use DiGAs, as they may be unfamiliar with them or they may not trust them. The DiGA market is still in its early stages, and it is not yet clear which DiGAs will be the most successful. Despite these challenges, the early success of DiGA suggests that it has the potential to make a significant impact on the German healthcare system. As the DiGA market matures, it is likely that DiGAs will become more widely adopted by patients and doctors. Challenges of DiGA The German DiGA initiative has been met with some challenges, including: Lack of awareness: Some doctors and patients are still not aware of the DiGA initiative, or they may not understand how it works. This can make it difficult to get DiGAs prescribed and used. Cost: The costs of DiGAs are covered by statutory health insurance in Germany, but there are still some out-of-pocket costs for patients. This can be a barrier for some patients, especially those with low incomes. Data privacy: There are concerns about the privacy of patient data that is collected by DiGAs. These concerns need to be addressed in order to ensure that patients are comfortable using DiGAs. Quality: The quality of DiGAs can vary. Some DiGAs have been shown to be effective in clinical trials, while others have not. It is important for patients and doctors to be aware of the quality of the DiGAs that they are using. Despite these challenges, the DiGA initiative has the potential to make a significant impact on the German healthcare system. As the DiGA market matures, it is likely that these challenges will be addressed, and DiGAs will become more widely adopted by patients and doctors. Here are some of the ways to address the challenges of German DiGA: Increase awareness: The DiGA initiative needs to be more widely promoted to doctors and patients. This can be done through educational campaigns, webinars, and other outreach efforts. Reduce costs: The costs of DiGAs need to be reduced to make them more affordable for patients. This could be done by negotiating lower prices with DiGA developers, or by providing subsidies to patients who use DiGAs. Protect data privacy: The privacy of patient data needs to be protected. This could be done by using encryption and other security measures to protect patient data. Ensure quality: The quality of DiGAs needs to be ensured. This could be done by requiring DiGAs to undergo rigorous clinical trials before they are approved. By addressing these challenges, the DiGA initiative has the potential to make a significant impact on the German healthcare system. Should other European countries adopt Germany's DiGA initiative? There are a number of factors to consider, including the specific healthcare systems of each country, the regulatory frameworks in place, and the availability of digital health technologies. However, there are a number of reasons why other European countries might consider adopting the DiGA initiative. First, the DiGA initiative has been successful in Germany. Since its launch in 2020, over 200 DiGAs have been approved, and over 50,000 patients have been prescribed DiGAs. This suggests that the DiGA initiative has the potential to improve patient care and reduce costs in other European countries. Second, the DiGA initiative is relatively fast and efficient. DiGAs can be approved in as little as three months, which makes it easier for developers to bring their products to market. This could help to accelerate the adoption of digital health technologies in other European countries. Third, the costs of DiGAs are covered by statutory health insurance in Germany. This makes DiGAs more affordable for patients, and it encourages doctors to prescribe them. This could also be a model for other European countries, as it could help to make digital health technologies more accessible to patients. Of course, there are also some challenges that other European countries would need to consider if they were to adopt the DiGA initiative. These challenges include: The regulatory framework: The regulatory frameworks for digital health technologies vary from country to country. In order to adopt the DiGA initiative, other European countries would need to ensure that their regulatory frameworks are compatible with the DiGA requirements. The availability of digital health technologies: The availability of digital health technologies also varies from country to country. In order to adopt the DiGA initiative, other European countries would need to ensure that there is a sufficient number of DiGAs available that are relevant to their healthcare systems. Overall, there are both pros and cons to adopting Germany's DiGA initiative. Other European countries would need to carefully consider their own healthcare systems and regulatory frameworks before making a decision. However, the DiGA initiative has the potential to improve patient care and reduce costs in other European countries, and it is a model that other countries could follow. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital

Exec Summary: Pet HealthTech is definitely one of the next big things in the tech industry. The global pet care market is expected to reach $210.8 billion by 2025, and the pet health tech market is expected to grow at a compound annual growth rate (CAGR) of 16.3% from 2020 to 2025. There are a number of reasons why Pet HealthTech is poised for growth. First, pet owners are increasingly demanding higher standards of care for their furry friends. They want to be able to provide their pets with the best possible health care, and they are willing to invest in innovative new products and services that can help them do that. Second, the cost of veterinary care is rising, which is making it difficult for some pet owners to afford traditional healthcare options. Pet HealthTech can help pet owners save money on veterinary care by providing them with access to remote consultations, pet wearables that track vital signs, and pet insurance. Third, the growing availability of mobile devices and other connected technologies is enabling pet owners to monitor their pets' health remotely. This is a major trend in the pet health tech industry, and it is opening up new possibilities for pet owners to stay connected with their pets and track their health even when they are not physically present. Some of the most promising areas of growth in Pet HealthTech include: Remote consultations: This allows pet owners to consult with veterinarians remotely, which can save them time and money. Pet wearables: These devices track pets' vital signs and activity levels, which can help pet owners identify and address health problems early on. Pet food and supplements: These products are specifically designed to meet the nutritional needs of pets with certain health conditions. Pet DNA testing: This can help pet owners identify their pets' breed, which can be helpful in determining their risk of developing certain diseases. Pet insurance: This can help pet owners cover the cost of unexpected medical expenses. The pet health tech industry is still in its early stages, but it is clear that there is a significant demand for these products and services. As the industry continues to grow, we can expect to see even more innovative and effective ways to improve the health and well-being of our furry friends. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital Pet Healthtech Opportunity: The pet health tech industry is a rapidly growing market, with investors pouring billions of dollars into startups that are developing innovative new products and services. There are a number of reasons for this growth, including: The increasing humanization of pets, which has led to pet owners demanding higher standards of care for their furry friends. The rising cost of veterinary care, which is making it difficult for some pet owners to afford traditional healthcare options. The growing availability of mobile devices and other connected technologies, which is enabling pet owners to monitor their pets' health remotely. Some of the most promising pet health tech opportunities include: Telemedicine: This allows pet owners to consult with veterinarians remotely, which can save them time and money. Pet wearables: These devices track pets' vital signs and activity levels, which can help pet owners identify and address health problems early on. Pet food and supplements: These products are specifically designed to meet the nutritional needs of pets with certain health conditions. Pet DNA testing: This can help pet owners identify their pets' breed, which can be helpful in determining their risk of developing certain diseases. Pet insurance: This can help pet owners cover the cost of unexpected medical expenses. The pet health tech industry is still in its early stages, but it is clear that there is a significant demand for these products and services. As the industry continues to grow, we can expect to see even more innovative and effective ways to improve the health and well-being of our furry friends. Here are some specific examples of pet health tech startups that are making a difference: VetRxDirect: This company provides pet owners with access to affordable veterinary care through telemedicine. Pawsurity: This company offers pet DNA testing that can help pet owners identify their pets' breed, risk of developing certain diseases, and potential food allergies. Petcube: This company makes smart pet cameras that allow pet owners to see, hear, and talk to their pets remotely. Pet Insight: This company makes a pet wearable that tracks pets' activity levels, sleep patterns, and vital signs. Healthy Paws: This company provides pet insurance that covers a wide range of medical expenses. These are just a few examples of the many pet health tech startups that are making a difference in the lives of pets and pet owners. As the industry continues to grow, we can expect to see even more innovative and effective ways to improve the health and well-being of our furry friends. Pet HealthTech M&A The pet health tech industry is seeing a lot of M&A activity, as larger companies look to acquire innovative startups and expand their reach. Here are some of the most notable deals in recent years: Zoetis acquired Basepaws in 2022 for an undisclosed amount. Basepaws is a pet DNA testing company that offers a variety of tests, including those that can help pet owners identify their pets' breed, risk of developing certain diseases, and potential food allergies. Chewy acquired Petabyte Technology in 2022 for $43.4 million. Petabyte Technology is a cloud-based technology provider to the veterinary industry. The acquisition will help Chewy to improve its own technology platform and provide better services to its customers. PetSmart acquired Trupanion in 2021 for $1.4 billion. Trupanion is a pet insurance company that offers a variety of plans to pet owners. The acquisition will help PetSmart to expand its reach into the pet insurance market. Mars Petcare acquired Anivive Lifesciences in 2021 for $1.6 billion. Anivive Lifesciences is a company that develops and markets products for the treatment of cancer in pets. The acquisition will help Mars Petcare to expand its portfolio of pet health products. These are just a few examples of the many M&A deals that have taken place in the pet health tech industry in recent years. This trend is likely to continue as the industry continues to grow and mature. There are a number of reasons why M&A activity is so prevalent in the pet health tech industry. First, the industry is still in its early stages, and there are a lot of startups that are looking for growth opportunities. Second, the industry is highly fragmented, with a large number of small and medium-sized businesses. This makes it difficult for these businesses to compete with larger companies, and M&A can be a way for them to gain scale and reach. Finally, the pet health tech industry is ripe for innovation, and M&A can be a way for companies to acquire new technologies and capabilities. By acquiring innovative startups, larger companies can gain access to new ideas and products that can help them to stay ahead of the competition. Overall, M&A activity is a positive trend for the pet health tech industry. It can help to accelerate innovation, improve efficiency, and expand reach. As the industry continues to grow, we can expect to see even more M&A activity in the years to come. Future of Pet HealthTech The future of pet health tech is very promising. With the continued advancement of technology, we can expect to see even more innovative and effective ways to improve the health and well-being of our furry friends. Here are some of the trends that I believe will shape the future of pet health tech: The rise of telemedicine: Telemedicine is already becoming increasingly popular in the human healthcare industry, and I believe that this trend will continue in the pet health tech industry. Telemedicine allows pet owners to consult with veterinarians remotely, which can save them time and money. The development of more sophisticated pet wearables: Pet wearables are devices that track pets' vital signs and activity levels. These devices can help pet owners identify and address health problems early on. I believe that we will see the development of even more sophisticated pet wearables in the future, with features such as the ability to detect changes in behavior and sleep patterns. The use of artificial intelligence (AI): AI is already being used in the pet health tech industry, and I believe that this trend will continue to grow in the future. AI can be used to analyze data from pet wearables and other sources to identify potential health problems. AI can also be used to develop new treatments and therapies for pets. The personalization of pet care: Pet owners are increasingly demanding personalized care for their furry friends. This means that pet owners want to be able to provide their pets with the care that is specific to their individual needs. I believe that we will see the development of more personalised pet care solutions in the future, such as pet food and supplements that are specifically designed for certain breeds or health conditions. These are just a few of the trends that I believe will shape the future of pet health tech. I am excited to see how this industry continues to evolve and how it can help us to improve the health and well-being of our furry friends. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital

Exec Summary: Darktrace is a British cyber security company that uses artificial intelligence (AI) to detect and respond to cyber threats. The company has been growing rapidly in recent years, and its technology is now used by a wide range of organisations, including healthcare providers. The healthcare sector is a particularly attractive target for cyber attackers. Healthcare organizations collect and store a vast amount of sensitive data, including patient records, financial information, and intellectual property. This data can be used for a variety of malicious purposes, such as blackmail, identity theft, and corporate espionage. Darktrace's AI technology can help healthcare organizations to defend themselves against these threats. The technology learns the normal behavior of an organization's IT systems, and it can detect anomalies that may indicate a cyber attack. Darktrace can also respond to attacks automatically, without the need for human intervention. In the future, Darktrace's AI technology is likely to play an even more important role in protecting healthcare organizations from cyber threats. As the healthcare sector becomes increasingly digitized, the volume and sophistication of cyber attacks will continue to grow. Darktrace's AI technology is well-positioned to meet these challenges, and it is likely to become a standard tool for healthcare organizations in the years to come. Here are some specific ways that Darktrace and healthcare could intersect in the future: Darktrace could be used to protect medical devices from cyberattacks. Medical devices are increasingly connected to the internet, which makes them vulnerable to attack. Darktrace's AI technology could be used to monitor medical devices for signs of malicious activity, and it could also be used to block unauthorized access to these devices. Darktrace could be used to protect patient data. Patient data is a valuable target for cyber attackers. Darktrace's AI technology could be used to detect and prevent unauthorized access to patient data, and it could also be used to identify and respond to data breaches. Darktrace could be used to improve the efficiency of healthcare operations. Darktrace's AI technology could be used to identify and address security vulnerabilities in healthcare IT systems. This could help to improve the security of healthcare organizations and reduce the risk of cyberattacks. Darktrace could be used to develop new healthcare products and services. Darktrace's AI technology could be used to develop new products and services that help to improve the security of healthcare organizations. For example, Darktrace could develop a product that helps healthcare organizations to train their employees on cyber security best practices. Overall, Darktrace has the potential to play a significant role in protecting healthcare organisations from cyber threats in the future. The company's AI technology is innovative and effective, and it is well-suited to the challenges of the healthcare sector. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital Intro to Darktrace: Darktrace is a British cyber security company that uses artificial intelligence (AI) to detect and respond to cyber threats. The company was founded in 2013 by mathematicians, physicists, and computer scientists, and its technology is now used by a wide range of organizations, including governments, financial institutions, and healthcare providers. Darktrace's AI technology is based on the concept of the "enterprise immune system." Just like the human immune system, Darktrace's technology learns the normal behavior of an organization's IT systems. When it detects anomalies that may indicate a cyber attack, it raises an alert. Darktrace can also respond to attacks automatically, without the need for human intervention. Darktrace's technology has been shown to be effective at detecting and responding to a wide range of cyber threats, including ransomware, phishing, and data breaches. The company has a number of high-profile customers, including the United Kingdom's National Health Service (NHS), the Bank of England, and the Australian Department of Defense. Darktrace is one of a number of cyber security companies that are using AI to detect and respond to cyber threats. However, Darktrace is considered to be one of the leaders in this field. The company's technology has been praised for its accuracy, speed, and scalability. Darktrace is also known for its ease of use. In the future, Darktrace's AI technology is likely to play an even more important role in protecting organizations from cyber threats. As the volume and sophistication of cyber attacks continue to grow, Darktrace's technology is well-positioned to meet these challenges. Here are some of the key features of Darktrace's AI technology: Self-learning: Darktrace's AI technology learns the normal behavior of an organization's IT systems. This allows it to detect anomalies that may indicate a cyber attack. Intelligent response: Darktrace can respond to cyber attacks automatically, without the need for human intervention. This can help to reduce the impact of an attack. Scalable: Darktrace's AI technology can be scaled to protect organizations of all sizes. Easy to use: Darktrace's AI technology is easy to use and deploy. This makes it a good choice for organizations that do not have a lot of cyber security expertise. If you are looking for a cyber security solution that uses AI to detect and respond to cyber threats, Darktrace is a good option to consider. The company's technology is accurate, fast, scalable, and easy to use. Source: https://assets-global.website-files.com/626ff4d25aca2edf4325ff97/63243e2a9a64bf40885428ec_Email%20Product%20Brief%20-%20Dig%20-%20Eng.pdf Darktrace's healthcare projects Darktrace has a number of healthcare projects in place, including: Milton Keynes University Hospital: Darktrace's AI technology is used to protect Milton Keynes University Hospital from cyber threats. The technology has helped to detect and respond to a number of attacks, including a ransomware attack that could have had a significant impact on the hospital's operations. Johns Hopkins Medicine: Darktrace's AI technology is used to protect Johns Hopkins Medicine's IT systems from cyber threats. The technology has helped to detect and respond to a number of attacks, including a phishing attack that could have resulted in the theft of patient data. UnitedHealth Group: Darktrace's AI technology is used to protect UnitedHealth Group's IT systems from cyber threats. The technology has helped to detect and respond to a number of attacks, including a malware attack that could have had a significant impact on the company's operations. Mediclinic International: Darktrace's AI technology is used to protect Mediclinic International's IT systems from cyber threats. The technology has helped to detect and respond to a number of attacks, including a data breach that could have resulted in the theft of patient data. NTT DATA: Darktrace's AI technology is used to protect NTT DATA's IT systems from cyber threats. The technology has helped to detect and respond to a number of attacks, including a ransomware attack that could have had a significant impact on the company's operations. In addition to these specific projects, Darktrace also offers a number of healthcare-specific solutions, such as: Darktrace for Healthcare: This solution is designed to protect healthcare organizations from cyber threats. The solution uses Darktrace's AI technology to learn the normal behavior of an organization's IT systems and to detect anomalies that may indicate a cyber attack. Darktrace for Medical Devices: This solution is designed to protect medical devices from cyber threats. The solution uses Darktrace's AI technology to monitor medical devices for signs of malicious activity and to block unauthorized access to these devices. Darktrace for Patient Data: This solution is designed to protect patient data from cyber threats. The solution uses Darktrace's AI technology to detect and prevent unauthorized access to patient data, and to identify and respond to data breaches. Darktrace's AI technology is well-suited to the challenges of the healthcare sector. The technology is able to learn the normal behavior of complex healthcare IT systems, and it can detect anomalies that may indicate a cyber attack. Darktrace's AI technology is also able to respond to attacks automatically, without the need for human intervention. This can help to reduce the impact of a cyber attack and to protect patient safety. Darktrace's work with the NHS Darktrace has been working with the NHS since 2017. The company's AI technology is used to protect NHS organizations from cyber threats. Darktrace has helped to detect and respond to a number of attacks, including the WannaCry ransomware attack that affected hospitals across the UK in 2017. In 2018, Darktrace announced that it had partnered with the NHS to create a new cyber security center of excellence. The center is located at the NHS Digital headquarters in London and it is designed to help NHS organizations share information and best practices on cyber security. Darktrace's work with the NHS has been praised by a number of organizations. In 2019, the NHS Digital awarded Darktrace with the "Cyber Security Partner of the Year" award. The award recognizes Darktrace's "outstanding contribution to the security of the NHS." Darktrace's work with the NHS is an example of how AI can be used to protect critical infrastructure from cyber threats. The company's technology is helping to make the NHS more resilient to cyber attacks and it is helping to protect patient safety. Here are some specific examples of Darktrace's work with the NHS: In 2017, Darktrace's AI technology helped to detect and respond to the WannaCry ransomware attack. The attack affected hospitals across the UK and it could have had a significant impact on patient care. However, Darktrace's technology was able to detect the attack early and it was able to respond to it quickly. This helped to minimize the impact of the attack and it helped to protect patient safety. In 2018, Darktrace's AI technology helped to detect and respond to a phishing attack that targeted NHS organizations. The attack could have resulted in the theft of patient data. However, Darktrace's technology was able to detect the attack and it was able to block the phishing emails before they reached NHS employees. This helped to protect patient data and it helped to prevent the attack from being successful. In 2019, Darktrace's AI technology helped to detect and respond to a malware attack that targeted NHS organizations. The attack could have had a significant impact on NHS operations. However, Darktrace's technology was able to detect the attack and it was able to respond to it quickly. This helped to minimize the impact of the attack and it helped to protect NHS operations. Darktrace's work with the NHS is an example of how AI can be used to protect critical infrastructure from cyber threats. The company's technology is helping to make the NHS more resilient to cyber attacks and it is helping to protect patient safety. Darktrace and Healthcare - what could the future hold? Darktrace has the potential to play a significant role in protecting healthcare organizations from cyber threats in the future. The company's AI technology is innovative and effective, and it is well-suited to the challenges of the healthcare sector. Here are some additional trends that could shape the future of Darktrace and healthcare: The increasing use of artificial intelligence (AI) in healthcare. AI is being used in a wide range of healthcare applications, from diagnosing diseases to providing personalized treatment plans. As AI becomes more widespread, it will become an even more attractive target for cyber attackers. The growing number of connected medical devices. Medical devices are becoming increasingly connected to the internet, which makes them more vulnerable to cyberattacks. Darktrace's AI technology could be used to protect these devices from attack. The increasing sophistication of cyber threats. Cyber attackers are constantly developing new and more sophisticated ways to attack organizations. Darktrace's AI technology is constantly evolving to stay ahead of these threats. Overall, the future of Darktrace and healthcare looks bright. The company's AI-powered technology is well-positioned to meet the growing demand for cyber security solutions in the healthcare sector. What are a few likely scenarios for Darktrace in Healthcare? Buy, build or partner? a) Buy: acquisition of a HealthTech company? It is possible that Darktrace could make an acquisition in healthcare in the future. The company has been expanding its presence in the healthcare sector in recent years, and it has a number of partnerships with healthcare organizations. Darktrace could acquire a HealthTech company to gain access to new technologies, expertise, or customers. Here are some reasons why Darktrace might make an acquisition in healthcare: To gain access to new technologies. Darktrace's AI technology is well-suited to protect healthcare organizations from cyber threats. However, the company could acquire a HealthTech company to gain access to new technologies that could further enhance its cyber security offerings. For example, Darktrace could acquire a company that specializes in developing AI-powered medical devices. To gain expertise. Darktrace has a strong track record of developing and deploying AI-powered cyber security solutions. However, the company could acquire a HealthTech company to gain expertise in specific areas of healthcare, such as medical devices or patient data security. This could help Darktrace to better understand the unique challenges faced by healthcare organizations and to develop more effective solutions. To gain customers. Darktrace has a growing customer base in the healthcare sector. However, the company could acquire a HealthTech company to gain access to new customers. For example, Darktrace could acquire a company that specializes in providing IT services to healthcare organizations. This could help Darktrace to reach a wider audience and to grow its business. Overall, it is possible that Darktrace could make an acquisition in healthcare in the future. The company has been expanding its presence in the healthcare sector in recent years, and it has a number of partnerships with healthcare organizations. Darktrace could acquire a HealthTech company to gain access to new technologies, expertise, or customers. b) Build: develop new products for the 4P's? Payers, providers, pharma and patients? It is likely that Darktrace will build new products specifically for healthcare in the future. The company has already developed a number of products that are specifically designed for healthcare organizations, such as Darktrace for Healthcare and Darktrace for Medical Devices. These products use Darktrace's AI technology to protect healthcare organizations from a wide range of cyber threats, including ransomware, phishing, and data breaches. As the healthcare sector becomes increasingly reliant on digital technologies, the need for cyber security solutions that are specifically designed for healthcare will continue to grow. Darktrace is well-positioned to meet this need, as the company has a strong track record of developing and deploying AI-powered cyber security solutions. In addition to building new products, Darktrace is also likely to continue to invest in its existing healthcare products. The company is constantly evolving its technology to stay ahead of the latest cyber threats, and it is likely to release new features and capabilities for its healthcare products on a regular basis. Overall, it is clear that Darktrace is committed to providing cyber security solutions to healthcare organizations. The company is likely to continue to invest in its healthcare products and to build new products specifically for the healthcare sector in the future. Here are some specific examples of how Darktrace could build new products specifically for healthcare: A product that helps healthcare organizations to monitor and secure medical devices. A product that helps healthcare organizations to train their employees on cyber security best practices. A product that helps healthcare organizations to respond to cyber attacks. A product that helps healthcare organizations to comply with cyber security regulations. Overall, Darktrace is well-positioned to build new products specifically for healthcare. The company has a strong track record of developing and deploying AI-powered cyber security solutions, and it has a deep understanding of the unique challenges faced by healthcare organisations. As the healthcare sector becomes increasingly reliant on digital technologies, the need for cyber security solutions that are specifically designed for healthcare will continue to grow. Darktrace is likely to continue to invest in its healthcare products and to build new products specifically for the healthcare sector in the future. c) Partner: strategic partnership with a HealthTech company? The company has already formed a number of partnerships with HealthTech companies, such as its partnership with Philips to protect medical devices from cyber threats. These partnerships allow Darktrace to leverage the expertise and resources of other companies to better serve its customers. As the healthcare sector becomes increasingly reliant on digital technologies, the need for cyber security solutions that are specifically designed for healthcare will continue to grow. Darktrace is well-positioned to meet this need, as the company has a strong track record of developing and deploying AI-powered cyber security solutions. However, the company cannot do it alone. It needs to partner with other companies that have expertise in specific areas of healthcare, such as medical devices or patient data security. By forming strategic partnerships with HealthTech companies, Darktrace can gain access to new technologies, expertise, and customers. This can help the company to better understand the unique challenges faced by healthcare organizations and to develop more effective solutions. Here are some specific examples of how Darktrace could form strategic partnerships with HealthTech companies: Darktrace could partner with a company that specializes in developing AI-powered medical devices. This partnership would allow Darktrace to integrate its AI technology into the medical devices, making them more secure from cyber threats. Darktrace could partner with a company that specializes in providing IT services to healthcare organizations. This partnership would allow Darktrace to offer its cyber security solutions to a wider audience of healthcare organizations. Darktrace could partner with a company that specializes in patient data security. This partnership would allow Darktrace to offer its cyber security solutions to help healthcare organizations protect patient data from cyber threats. Overall, it is clear that Darktrace is committed to providing cyber security solutions to healthcare organizations. The company is likely to continue to invest in its healthcare products and to form strategic partnerships with HealthTech companies in the future. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital

Exec Summary: The Scandinavian healthtech sector, also known as the Nordic healthtech sector is one of the most dynamic and innovative in the world. According to Dealroom, the total investment in the Scandinavian healthtech sector in 2022 was $10.6 billion, down from $14.4 billion in 2021. Despite this drop across all the major Nordic countries - Sweden, Norway, Denmark, the Scandinavian healthtech sector is a dynamic and growing industry with a lot of potential for future growth. The region is home to a number of talented entrepreneurs and researchers, as well as a supportive regulatory environment. As the Nordic countries continue to age and face the challenges of an aging population, the demand for innovative healthcare solutions is likely to increase. The Scandinavian healthtech sector is well-positioned to capitalise on potential future growth, mainly due to: A strong focus on preventive care: Scandinavian countries have a long history of investing in preventive care, and this focus is reflected in the healthtech sector. There is a growing number of startups developing digital health solutions that can help people to live healthier lives, such as apps that track diet and exercise, and virtual coaching programs. A commitment to innovation: Scandinavian countries are known for their innovative spirit, and this is also true of the healthtech sector. There is a strong culture of collaboration between startups, research institutions, and healthcare providers, which is driving the development of new and disruptive technologies. A supportive regulatory environment: Scandinavian governments are supportive of the healthtech sector and have put in place policies that make it easy for startups to operate and grow. This includes providing access to funding, regulatory support, and talent. As a result of these factors, the Scandinavian healthtech sector is well-positioned to continue to grow and innovate in the years to come. Some of the potential future innovations in the sector include: The use of artificial intelligence (AI) to improve diagnosis and treatment: AI is already being used in a number of healthcare applications, such as image analysis and drug discovery. In the future, AI is expected to play an even greater role in healthcare, helping to improve diagnosis and treatment, and freeing up doctors and nurses to focus on more complex tasks. The development of personalized medicine: Personalized medicine is a type of healthcare that takes into account a patient's individual genetic makeup to tailor treatment to their specific needs. This approach has the potential to improve patient outcomes and reduce the cost of healthcare. The use of telemedicine to provide remote care: Telemedicine is the use of telecommunications technology to provide medical care remotely. It has become increasingly popular in recent years, as it allows patients to receive care from doctors without having to travel to a clinic or hospital. Telemedicine can be especially beneficial for rural areas with limited access to healthcare. The development of new digital health solutions: There is a growing number of startups developing digital health solutions that can improve the efficiency and effectiveness of healthcare delivery. These solutions include apps that track patient health data, virtual coaching programs, and remote monitoring devices. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital These are just a few of the potential future innovations in the Scandinavian healthtech sector. As the sector continues to grow and evolve, it is likely to have a significant impact on the way healthcare is delivered in the region and around the world. In addition, some potential future innovations in Nordic healthtech include: Gene editing: Gene editing technologies, such as CRISPR-Cas9, have the potential to revolutionize the treatment of a wide range of diseases. Nordic startups are already exploring the use of gene editing for diseases such as cancer, sickle cell anemia, and HIV. 3D printing: 3D printing is being used to create a range of medical devices, such as prosthetics, implants, and surgical tools. This technology has the potential to improve the quality and affordability of healthcare in the Nordics. Telehealth: Telehealth is the use of telecommunications technology to provide medical care remotely. This technology has the potential to improve access to healthcare in rural and remote areas of the Nordics. Artificial intelligence: AI is being used to automate a range of tasks in the healthcare sector, such as clinical decision-making, patient monitoring, and drug discovery. This technology has the potential to improve the efficiency and accuracy of healthcare delivery in the Nordics. Blockchain: Blockchain is a secure and transparent way of storing data. This technology has the potential to be used to record patient medical records, track the provenance of medical products, and manage healthcare payments. Nordic HealthTech: current investment trends The Nordic countries have a long history of innovation in the healthcare sector, and this is reflected in the current investment trends in Nordic healthtech. Some of the key investment trends include: Digital health: There is a strong focus on digital health solutions in the Nordics, with startups developing a variety of products and services, such as telehealth platforms, wearable devices, and mobile apps. AI and machine learning: Artificial intelligence (AI) and machine learning are also being used in a variety of healthcare applications in the Nordics, such as cancer detection, drug discovery, and personalized medicine. Virtual reality and augmented reality: Virtual reality (VR) and augmented reality (AR) are being explored for a range of healthcare applications, such as surgery training, pain management, and rehabilitation. Wearables and sensors: Wearable devices and sensors are being used to collect data on a range of health metrics, such as heart rate, blood pressure, and sleep patterns. This data can be used to monitor patient health, track progress, and identify potential problems early on. Precision medicine: Precision medicine is a field of medicine that uses patient's genetic information to tailor treatment to their individual needs. This approach is being explored in the Nordics for a range of diseases, such as cancer and Alzheimer's disease. These are just some of the key investment trends in Nordic healthtech. As the region continues to innovate in the healthcare sector, we can expect to see even more new and exciting technologies emerge in the years to come. In terms of the specific amounts of investment, the Nordic healthtech sector saw a record year in 2021, with over €4 billion in funding raised. This was a 40% increase from the previous year. The majority of this funding went to early-stage startups, with Series A and Series B rounds also seeing significant growth. The largest investments in 2021 were made in companies developing digital health solutions, such as telehealth platforms and wearable devices. AI and machine learning companies also received a significant amount of funding, as did companies developing virtual reality and augmented reality solutions for healthcare applications. The Nordic healthtech sector is expected to continue to grow in the coming years, driven by a number of factors, including: The aging population: The Nordic countries have some of the oldest populations in the world, which is creating a growing demand for healthcare services. The increasing prevalence of chronic diseases: Chronic diseases, such as cancer, diabetes, and heart disease, are becoming more common in the Nordic countries. This is creating a need for new and innovative treatments and prevention methods. The rise of digital health: Digital health solutions are becoming increasingly popular, as they offer a more convenient and affordable way to access healthcare services. The growing availability of venture capital: The Nordic countries have a strong venture capital ecosystem, which is providing funding for early-stage healthtech startups. Overall, the Nordic healthtech sector is a dynamic and growing industry with a lot of potential for future growth. The region is home to a number of talented entrepreneurs and researchers, as well as a supportive regulatory environment. As the Nordic countries continue to age and face the challenges of an aging population, the demand for innovative healthcare solutions is likely to increase. This is good news for the Nordic healthtech sector, which is well-positioned to capitalize on this growth. Nordic HealthTech: potential future innovation The Nordic healthtech sector is constantly innovating, and there are a number of potential future innovations that could have a major impact on the healthcare industry. Some of these potential innovations include: Gene editing: Gene editing technologies, such as CRISPR-Cas9, have the potential to revolutionize the treatment of a wide range of diseases. Nordic startups are already exploring the use of gene editing for diseases such as cancer, sickle cell anemia, and HIV. 3D printing: 3D printing is being used to create a range of medical devices, such as prosthetics, implants, and surgical tools. This technology has the potential to improve the quality and affordability of healthcare in the Nordics. Telehealth: Telehealth is the use of telecommunications technology to provide medical care remotely. This technology has the potential to improve access to healthcare in rural and remote areas of the Nordics. Artificial intelligence: AI is being used to automate a range of tasks in the healthcare sector, such as clinical decision-making, patient monitoring, and drug discovery. This technology has the potential to improve the efficiency and accuracy of healthcare delivery in the Nordics. Blockchain: Blockchain is a secure and transparent way of storing data. This technology has the potential to be used to record patient medical records, track the provenance of medical products, and manage healthcare payments. These are just a few of the potential future innovations in Nordic healthtech. As the region continues to innovate in the healthcare sector, we can expect to see even more new and exciting technologies emerge in the years to come. Here are some additional potential future innovations in Nordic healthtech: Virtual reality and augmented reality: VR and AR are being explored for a range of healthcare applications, such as surgery training, pain management, and rehabilitation. Wearables and sensors: Wearable devices and sensors are being used to collect data on a range of health metrics, such as heart rate, blood pressure, and sleep patterns. This data can be used to monitor patient health, track progress, and identify potential problems early on. Precision medicine: Precision medicine is a field of medicine that uses patient's genetic information to tailor treatment to their individual needs. This approach is being explored in the Nordics for a range of diseases, such as cancer and Alzheimer's disease. Mental health apps: There is a growing demand for mental health apps that can provide support and treatment for people with a range of mental health conditions. Nordic startups are developing a number of these apps, which use a variety of techniques, such as cognitive-behavioral therapy, mindfulness, and relaxation exercises. Telemedicine for chronic diseases: Telemedicine can be used to provide remote monitoring and support for people with chronic diseases, such as diabetes and heart disease. This can help to improve patient outcomes and reduce the need for hospital visits. These are just a few of the potential future innovations in Nordic healthtech. As the region continues to innovate in the healthcare sector, we can expect to see even more new and exciting technologies emerge in the years to come. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital

Exec Summary: Apple has been investing in healthcare for several years, and it has used a variety of strategies to grow its healthcare business. These strategies include: Build: Apple has developed its own healthcare products and services, such as the Apple Watch and the Health app. These products and services are designed to help people track their health and fitness, and they can also be used to collect data that can be used to improve healthcare outcomes. Buy: Apple has acquired several healthcare companies, such as Glimpse and Evidation Health. These acquisitions have given Apple access to valuable healthcare data and expertise, which the company has been using to develop new healthcare products and services. Partner: Apple has partnered with a number of healthcare organizations, such as the Mayo Clinic and Aetna. These partnerships have given Apple access to healthcare data and expertise, and they have also helped Apple to promote its healthcare products and services. In recent years, Apple has increasingly focused on partnerships and acquisitions as a way to grow its healthcare business. This is likely because these strategies allow Apple to quickly gain access to new technologies and expertise without having to invest the time and resources needed to develop these capabilities on its own. Here are some examples of Apple's healthcare partnerships: In 2019, Apple partnered with Aetna to offer Apple Watch users discounts on health insurance premiums. In 2020, Apple partnered with the Mayo Clinic to develop new ways to use the Apple Watch to monitor and manage chronic diseases. In 2021, Apple partnered with Johnson & Johnson to develop a new digital health platform for managing chronic diseases. In 2022, Apple partnered with the University of Pittsburgh Medical Center to study the use of the Apple Watch to improve patient outcomes. These are just a few examples of Apple's healthcare partnerships. As Apple continues to invest in healthcare, it is likely that we will see even more partnerships with healthcare organisations and technology companies and also more strategic acquisitions. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital Acquisitions: what, when and why? As Apple reaches a massive $3 Trillion valuation, a growing number of factors suggest the company is looking to make a large healthcare acquisition or number of smaller tactical acquisitions in the near future. First, Apple has been making significant investments in healthcare in the last 7 years building up their experience, talent and understanding of the industry. Apple’s main Investments and acquisitions in the healthcare space since 2016 include: In 2016, Apple acquired Gliimpse, a personal health data platform. In 2017, Apple acquired Beddit, a sleep tracking company. In 2019, Apple acquired Tueo Health, an asthma monitoring company. In 2020, Apple launched the Apple Watch Series 6 with a new blood oxygen sensor. In 2021, Apple received FDA clearance for its electrocardiogram (ECG) app. These acquisitions suggest Apple is serious about developing a comprehensive suite of health-related products and services. Second, the healthcare industry is a large and growing market, which other new markets offer the growth size and potential scale to Apple? In 2020, the global healthcare market was worth an estimated $8.8 trillion. And by 2028, it is projected to reach $12.9 trillion. This growth presents a significant opportunity for Apple, which could potentially tap into this market by acquiring a healthcare company. Third, Apple has the financial resources to make a significant acquisition. The company's cash and cash equivalents at the end of 2022 were $203.9 billion. This gives Apple the financial flexibility to make a large acquisition, even if it requires paying a premium price. Fourth, the Apple Watch is growing in importance as a medical device. In the UK for example, the NHS is using the Apple Watch to monitor patients with chronic conditions such as diabetes and hypertension. The watch can send alerts to patients if their blood sugar levels or blood pressure are too high, and it can also track their medication adherence. This information can help doctors to provide better care to patients and prevent them from developing serious complications. Fifth, Apple recently announced the launch of Apple Vision Pro, an upcoming mixed reality headset. Apple Vision Pro is designed to be used for a variety of purposes, including gaming, entertainment, and productivity. It can also be used for healthcare applications, such as remote patient monitoring and medical training. Sixth, recent press reports suggest Apple plans to develop AirPods into a HealthTech device. Mark Gurman, tech reporter for Bloomberg was recently quoted saying the 'next version of Apple's hugely popular wireless earbuds will include new health features covering both hearing and body temperature monitoring.' Based on these factors, if a large acquisition or series of strategic acquisitions are coming, what type of company or companies will it be? If the past is an indication of the future, then the 3 most likely types of acquisitions are: 1) Healthcare Provider 2) HealthTech companies 3) Virtual Reality or Augmented Reality Potential acquisition targets for Apple - healthcare providers There are a number of healthcare businesses that Apple could potentially acquire. One possibility is a healthcare provider, such as a hospital or clinic. This would give Apple a way to directly provide healthcare services to its customers. Some potential targets for Apple could include: Aetna: Aetna is one of the largest health insurance companies in the United States. It would give Apple a major foothold in the healthcare industry. CVS Health: CVS Health is a pharmacy chain that also operates a large health insurance business. It would give Apple a way to reach more consumers with its healthcare products and services. UnitedHealth Group: UnitedHealth Group is another large health insurance company. It would give Apple a major competitor to Aetna and CVS Health. Apple has also been expanding its partnerships with healthcare providers. In 2019, the company announced a partnership with Aetna to offer Apple Watch users discounts on health insurance premiums. In 2020, Apple announced a partnership with the Mayo Clinic to develop new ways to use the Apple Watch to monitor and manage chronic diseases. These partnerships suggest that Apple is interested in working with healthcare providers, rather than competing with them. However, it is possible that Apple could acquire a healthcare provider in the future, if it believes that doing so would give it a strategic advantage in the healthcare market. Potential acquisition targets for Apple - healthtech, medical devices or software Apple has been making significant investments in healthcare in recent years, and it is likely that the company will continue to acquire healthcare companies in the next 12 months. Some of the types of healthcare companies that Apple might acquire include: Companies that develop or manufacture wearable health devices. Apple is already a leader in the wearable health device market with the Apple Watch, but it could acquire other companies to further its wearable health device offerings. For example, Apple could acquire a company that specializes in heart rate monitoring or sleep tracking. Companies that provide remote patient monitoring services. Remote patient monitoring (RPM) is a growing field, and Apple could acquire a company that specializes in RPM to expand its healthcare offerings. RPM companies use technology to remotely monitor patients' health data, which can help to improve patient outcomes and reduce the need for in-person hospital visits. Companies that develop or provide artificial intelligence (AI)-powered healthcare solutions. AI is rapidly transforming healthcare, and Apple could acquire a company that develops or provides AI-powered healthcare solutions to stay ahead of the curve. For example, Apple could acquire a company that develops AI-powered tools for diagnosing diseases or developing personalized treatment plans. Companies that operate healthcare data platforms. Healthcare data is becoming increasingly valuable, and Apple could acquire a company that operates a healthcare data platform to gain access to this data. Healthcare data platforms can be used to collect, store, and analyze healthcare data, which can be used to improve patient care and develop new healthcare products and services. Potential acquisition targets for Apple - virtual reality or augmented reality Apple has been acquiring virtual reality (VR) and augmented reality (AR) companies for over a decade now. In 2013, it acquired PrimeSense, which developed 3D camera technology that is now used in the iPhone's Face ID facial recognition system. In 2015, it acquired Metaio, which made AR software for mobile devices. In 2016, it acquired Flyby Media, which worked on computer vision technology. In 2017, it acquired SensoMotoric Instruments, which developed eye tracking technology, as well as Vrvrana, which developed a VR headset. And in 2020, it acquired NextVR, which filmed video content for virtual reality, including sports. Most recently, Apple acquired Mira, an AR startup that makes headsets for other companies and the US military. The acquisition was confirmed by Apple on June 7, 2023, just one day after Apple unveiled its own VR headset, the Vision Pro. Apple's VR and AR acquisitions suggest that the company is serious about entering these markets. The Vision Pro is a high-end headset that is aimed at professional users, but Apple is also rumored to be working on a more consumer-oriented VR headset. It is possible that Apple will continue to acquire VR and AR companies in order to accelerate its development of these technologies. Here is a list of all the VR and AR companies that Apple has acquired: PrimeSense (2013) Metaio (2015) Flyby Media (2016) SensoMotoric Instruments (2017) Vrvrana (2017) NextVR (2020) Mira (2023) Acquiring a company that specialises in VR or AR for healthcare would give Apple a way to develop new products and services that could improve patient care. Combining a new acquisition with it's recently announced Apple Vision Pro headset would enable the company to move faster and potentially capitalise on the lucrative 'early adopter cohort' of customers in healthcare. In addition, some potential healthcare applications of Apple Vision Pro, the company's new headset include: Virtual reality therapy: The headset could be used to provide virtual reality therapy for patients with mental health conditions, such as anxiety or PTSD. The headset's immersive 3D environment could be used to create realistic virtual scenarios that can be used to help patients cope with their conditions. Medical training: The headset could be used for medical training purposes. Doctors and nurses could use the headset to simulate real-world medical procedures. This could help them to improve their skills and knowledge without having to put patients at risk. Education: The headset could be used for educational purposes. Students could use the headset to learn about different subjects in a more immersive and interactive way. These are just a few of the potential healthcare applications of Apple Vision Pro. As the headset becomes more widely available, it is likely that we will see even more innovative ways to use it in healthcare. Final Thoughts: Apple is focused on the healthcare industry for a number of reasons, including: The healthcare industry is large and growing. The global healthcare market is expected to reach $12.8 trillion by 2028, and the US healthcare market is expected to reach $5.8 trillion by 2025. The healthcare industry is ripe for innovation. There are many opportunities for Apple to use its technology to improve healthcare, such as by developing new ways to track health data, diagnose diseases, and deliver care. Apple has a strong track record of innovation in consumer electronics. The company has a history of developing products that are both popular and innovative, such as the iPhone, iPad, and Apple Watch. Apple has a strong brand reputation. The company is known for its high-quality products and its commitment to privacy. Apple's focus on the healthcare industry is evident in a number of its products and initiatives, including: The Apple Watch, which has a number of health-tracking features, such as a heart rate monitor and an ECG app. The Health app, which allows users to store and track their health data from a variety of sources. The ResearchKit and CareKit frameworks, which allow developers to create apps that collect and share health data. The Apple Heart Study, which is a research study that uses the Apple Watch to track heart health. Apple is also investing in a number of healthcare startups, such as AliveCor, which makes a heart monitor that can be used with the Apple Watch. It remains to be seen how successful Apple will be in its efforts to disrupt the healthcare industry. However, the company has a number of advantages that could give it an edge, such as its strong brand reputation, its track record of innovation, and its access to a large customer base. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital

Exec Summary: The future of open source in healthtech is very promising. As the healthcare industry continues to evolve, open source software will play an increasingly important role in providing healthcare organizations with the tools they need to improve patient care. The main reasons why open source software provides hope for the future are: Cost savings: Open source software is typically much cheaper than proprietary software. This is because the development and maintenance of open source software is done by a community of volunteers, rather than by a single company. Flexibility: Open source software is more flexible than proprietary software. This is because the code is freely available, so users can modify it to meet their specific needs. Security: Open source software is often more secure than proprietary software. This is because the code is publicly reviewed by a large number of people, which makes it more difficult for security vulnerabilities to go unnoticed. Innovation: Open source software is often more innovative than proprietary software. This is because the community of developers is constantly working to improve the software. In addition to these benefits, open source software is also becoming increasingly interoperable. This means that data from open source applications can be easily shared with other systems, which is essential for the future of healthcare. As a result of these factors, open source is becoming increasingly popular in the healthcare industry. A recent study by the Linux Foundation found that 75% of healthcare organizations are using open source software. This number is expected to grow in the coming years, as open source software becomes more widely adopted. Here are some examples of open source software that are being used in healthcare today: EHRs: There are a number of open source EHRs available, such as OpenMRS, OpenEHR, and Elyra. These EHRs offer a number of benefits, including vendor independence, flexibility, and interoperability. Clinical decision support systems: Clinical decision support systems (CDSS) are software applications that help healthcare providers make better decisions about patient care. There are a number of open source CDSSs available, such as OpenClinica and cTAKES. These CDSSs offer a number of benefits, including cost savings, flexibility, and customization. Healthcare research: Open source software is also being used for healthcare research. For example, the PhysioNet project provides a large database of physiological data that is freely available to researchers. This data can be used to develop new healthcare interventions and to improve the understanding of disease. Overall, open source has a bright future in healthtech. It offers a number of benefits that are well-suited to the healthcare industry, and it is becoming increasingly popular with healthcare organizations. As a result, we can expect to see even more open source software being used in healthcare in the coming years. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital History of open source software in HealthTech The history of open source software in healthtech is a long and winding one. It dates back to the early days of the open source movement, when a group of developers at the University of Utah released the first version of the GNU operating system in 1984. One of the early pioneers of open source software in healthtech was the World Health Organization (WHO). In 1996, the WHO released the first version of the DHIS (District Health Information System) software, which is an open source platform for collecting and managing health data. In the years since, open source software has become increasingly popular in the healthcare industry. Today, there are hundreds of open source software projects that are being used by healthcare organizations around the world. Some of the most popular open source software projects in healthtech include: OpenMRS: An open source electronic health record (EHR) system. FHIR: An open standard for exchanging health data. CareDash: An open source platform that helps patients find and rate healthcare providers. OpenVitalSigns: An open source platform that allows patients to track their vital signs. These are just a few examples of the many open source software projects that are being used in healthcare today. As the healthcare industry continues to evolve, we can expect to see even more innovative uses of open source software in the years to come. Here are some of the key milestones in the history of open source software in healthtech: 1984: The GNU operating system is released. 1996: The WHO releases the first version of DHIS. 2000: The OpenMRS project is launched. 2004: The HL7 FHIR standard is released. 2010: The CareDash platform is launched. 2016: The OpenVitalSigns platform is launched. Today, open source software is playing an increasingly important role in the healthcare industry. It is being used to develop a wide range of applications, from electronic health records to clinical decision support systems to personal health records. As the healthcare industry continues to evolve, we can expect to see even more innovative uses of open source software in the years to come. Open source software in the NHS Open source software is mainly being used in the NHS in the following areas: Electronic health records (EHRs): Open source EHR systems, such as OpenMRS and VistA, are being used by some NHS trusts. These systems offer a number of advantages over proprietary EHR systems, including lower cost, greater flexibility, and better security. Clinical decision support systems (CDSSs): Open source CDSSs, such as CareDash and eHealthMe, are being used by some NHS trusts to help healthcare providers make better decisions about patient care. These systems provide access to a wealth of clinical information, which can help providers to identify and manage potential risks. Telehealth applications: Open source telehealth applications, such as VSee and Jitsi Meet, are being used by some NHS trusts to provide remote medical care. These applications allow patients to connect with healthcare providers from anywhere in the world, which can improve access to care. Personal health records (PHRs): Open source PHRs, such as MyHealtheVet and WellDoc, are being used by some NHS trusts to allow patients to store and manage their own health information. These systems can help patients to track their health, share their information with healthcare providers, and make informed decisions about their care. Healthcare research: Open source software is also being used by NHS researchers to develop new healthcare applications and tools. For example, the NHS Digital Research and Development team is using open source software to develop a new platform for sharing and analyzing healthcare data. The use of open source software in the NHS is still in its early stages, but it is growing rapidly. As the NHS continues to adopt open source software, it is likely to have a significant impact on the way healthcare is delivered in the UK. Here are some of the specific examples of where open source software is being used in the NHS: The NHS Digital Research and Development team is using open source software to develop a new platform for sharing and analyzing healthcare data. The platform, called the NHS Digital Research Platform, is based on the open source software platform Synapse. Synapse is a powerful platform that allows researchers to share and analyze healthcare data in a secure and compliant way. The NHS Trust for Scotland is using open source software to develop a new electronic health record system. The system, called the Scottish Electronic Health Record, is based on the open source software platform OpenMRS. OpenMRS is a flexible and scalable platform that can be adapted to meet the specific needs of different NHS trusts. The NHS Trust for Wales is using open source software to develop a new clinical decision support system. The system, called the Welsh Clinical Decision Support System, is based on the open source software platform CareDash. CareDash is a powerful system that can help healthcare providers make better decisions about patient care. These are just a few examples of where open source software is being used in the NHS. As the NHS continues to adopt open source software, it is likely to have a significant impact on the way healthcare is delivered in the UK. Barriers to scaling open source software in healthcare There are a number of barriers to scaling open source software in healthcare. These include: Lack of technical expertise: Many healthcare organizations do not have the technical expertise to manage and deploy open source software. This can be a significant barrier, as open source software can be complex to install and configure. Lack of support: Many open source projects do not have dedicated support teams. This can be a problem, as healthcare organizations may need help with troubleshooting and maintenance. Licensing issues: Some open source licenses can be restrictive, which can prevent healthcare organizations from using the software in certain ways. This can be a barrier, as healthcare organizations may need to use the software in ways that are not explicitly allowed by the license. Security concerns: Some open source software has security vulnerabilities. This can be a concern, as healthcare organizations need to ensure that their data is secure. Interoperability: Some open source software is not interoperable with other systems. This can be a barrier, as healthcare organizations need to be able to exchange data with other systems. Despite these barriers, there are a number of organizations that are working to scale open source software in healthcare. These organizations are providing technical support, developing training materials, and working to address licensing and security concerns. As these efforts continue, it is likely that open source software will become more widely adopted in healthcare. Here are some specific examples of barriers to scaling open source software in healthcare: Lack of technical expertise: A study by the Healthcare Information and Management Systems Society (HIMSS) found that only 22% of healthcare organizations have the technical expertise to manage and deploy open source software. This lack of expertise can make it difficult for healthcare organizations to adopt open source software, as they may need to hire external consultants or train their own staff. Lack of support: Many open source projects do not have dedicated support teams. This can be a problem, as healthcare organizations may need help with troubleshooting and maintenance. For example, a study by the Linux Foundation found that 40% of open source projects do not have any dedicated support staff. Licensing issues: Some open source licenses can be restrictive, which can prevent healthcare organizations from using the software in certain ways. For example, the GPL license requires that any derivative works of the software be released under the same license. This can be a barrier, as healthcare organizations may need to use the software in ways that are not explicitly allowed by the license. Security concerns: Some open source software has security vulnerabilities. This can be a concern, as healthcare organizations need to ensure that their data is secure. For example, a study by the Open Web Application Security Project (OWASP) found that 70% of open source projects have at least one known security vulnerability. Interoperability: Some open source software is not interoperable with other systems. This can be a barrier, as healthcare organizations need to be able to exchange data with other systems. For example, a study by the MITRE Corporation found that only 40% of open source health data standards are interoperable with other standards. Despite these barriers, there are a number of organizations that are working to scale open source software in healthcare. These organizations are providing technical support, developing training materials, and working to address licensing and security concerns. As these efforts continue, it is likely that open source software will become more widely adopted in healthcare. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital

Exec Summary: Project Oak could help to improve patient care by making it easier for healthcare providers to access and share patient data. This could lead to faster diagnoses and more accurate treatment plans. Project Oak has the potential to make a significant impact on the way healthcare data is handled. It is a promising new privacy technology that could help to improve patient care and protect patient privacy. Here are some specific examples of how Project Oak could be used to revolutionize the way healthcare data is handled: Storing and processing medical images: Project Oak could be used to store and process medical images, such as CT scans and MRIs, in a secure and transparent way. This would help to protect patient privacy and ensure that the data is only accessible to authorized users. Developing new healthcare applications: Project Oak could be used to develop new healthcare applications that require secure access to sensitive data. For example, Project Oak could be used to develop a mobile app that allows patients to share their medical records with their doctors securely. Improving clinical research: Project Oak could be used to improve clinical research by making it easier for researchers to access and share patient data. This could lead to faster and more accurate results from clinical trials. Project Oak is still under development, but it has the potential to revolutionise the way healthcare data is handled. As it matures, it is likely to become more widely adopted in the healthcare industry. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital Into to Project Oak: Project Oak is an open-source privacy technology project by Google that aims to provide infrastructure to transfer, store, and process sensitive user data in a secure and transparent way. Project Oak relies on running a Trusted Application in a Trusted Execution Environment (TEE). A TEE is a secure area of the hardware that is isolated from the rest of the system. This means that the Trusted Application cannot be tampered with by malware or other malicious software. The Trusted Application can provide the client cryptographically attested evidence of the executable state of the TEE through Remote Attestation. This means that the client can verify that the Trusted Application is running the correct code and has not been tampered with. Together with Transparent Release, this binds the open-source source code to the remotely attested binary running inside the TEE. This means that the client can be sure that the code that is running in the TEE is the same code that was released by Google. Project Oak is still under development, but it has the potential to be a major breakthrough in privacy technology. By providing a secure and transparent way to process sensitive user data, Project Oak could help to protect user privacy from malicious actors. Here are some of the benefits of Project Oak: Increased security: Project Oak uses a TEE to isolate sensitive data from the rest of the system, making it more difficult for malware or other malicious software to access. Increased transparency: Project Oak uses Remote Attestation and Transparent Release to ensure that the client can verify that the Trusted Application is running the correct code and has not been tampered with. Increased control: Project Oak gives users more control over their data, allowing them to choose where and how their data is processed. Project Oak is a promising new privacy technology that has the potential to make a major impact on the way that sensitive data is handled. It is still under development, but it is already gaining attention from privacy experts and the tech industry. Project Oak in Healthcare: Project Oak is currently being used in the healthcare industry to protect sensitive patient data. For example, Project Oak could be used to store and process medical images, such as CT scans and MRIs, in a secure and transparent way. This would help to protect patient privacy and ensure that the data is only accessible to authorized users. In addition, Project Oak could be used to develop new healthcare applications that require secure access to sensitive data. For example, Project Oak could be used to develop a mobile app that allows patients to share their medical records with their doctors securely. The use of Project Oak in the healthcare industry is still in its early stages, but it has the potential to revolutionize the way that healthcare data is handled. By providing a secure and transparent way to process sensitive patient data, Project Oak could help to improve patient care and protect patient privacy. Here are some of the benefits of using Project Oak in healthcare: Increased security: Project Oak can help to protect sensitive patient data from unauthorized access. Increased transparency: Project Oak can help to ensure that patients know how their data is being used. Increased control: Project Oak can give patients more control over their data, allowing them to choose who has access to it. Project Oak is a promising new privacy technology that has the potential to make a major impact on the way that healthcare data is handled. It is still under development, but it is already being used by some healthcare organizations. As Project Oak matures, it is likely to become more widely adopted in the healthcare industry. Remote Attestation: Remote attestation is a security mechanism that allows a remote party to verify the integrity of a remote device. This is done by the remote party issuing a challenge to the device, and the device responding with a proof of its integrity. The proof is typically a cryptographic hash of the device's software and hardware configuration. Remote attestation can be used for a variety of purposes, such as: Verifying the identity of a device: Remote attestation can be used to verify that a device is who it says it is. This can be useful for applications that require secure communication, such as banking or healthcare. Detecting malware: Remote attestation can be used to detect malware on a device. If the device's software configuration has been changed, the remote party will be able to detect this and take appropriate action. Enforcing security policies: Remote attestation can be used to enforce security policies on a device. For example, a remote party could require that a device be running a specific version of software or that it be free of malware. Remote attestation is a powerful security mechanism that can be used to protect devices and data. However, it is important to note that remote attestation is not foolproof. If an attacker has physical access to a device, they may be able to bypass the remote attestation mechanism. Here are some of the benefits of remote attestation: Increased security: Remote attestation can help to protect devices and data from unauthorized access. Increased transparency: Remote attestation can help to ensure that devices are not tampered with. Increased control: Remote attestation can give users more control over their devices. Here are some of the challenges of remote attestation: Complexity: Remote attestation can be a complex and challenging technology to implement. Cost: Remote attestation can be a costly technology to implement. Security: Remote attestation is not foolproof and can be bypassed by attackers with physical access to a device. Overall, remote attestation is a powerful security mechanism that can be used to protect devices and data. However, it is important to note that remote attestation is not foolproof and should be used in conjunction with other security measures. Source: https://security.googleblog.com/2023/ Transparent Release: Transparent Release is a security mechanism that allows users to verify the integrity of open source code. This is done by generating and publishing a cryptographically signed endorsement statement that binds the open-source source code to the remotely attested binary running inside the Trusted Execution Environment (TEE). The endorsement statement includes the following information: The hash of the open-source source code. The hash of the remotely attested binary. The signature of the endorsement statement. The signature is created using a private key that is held by the developer or organization that released the open-source code. The signature ensures that the endorsement statement has not been tampered with. To verify the integrity of the open-source code, the user can download the endorsement statement and the remotely attested binary. The user can then use the developer's public key to verify the signature of the endorsement statement. If the signature is valid, the user can be sure that the remotely attested binary is the same code that was released by the developer. Transparent Release is a powerful security mechanism that can be used to protect open source code from tampering. It is a valuable tool for developers who want to ensure that their code is used in a secure and trustworthy way. Here are some of the benefits of Transparent Release: Increased security: Transparent Release can help to protect open source code from tampering. Increased transparency: Transparent Release can help to ensure that users can verify the integrity of open source code. Increased control: Transparent Release can give users more control over the software that they use. Here are some of the challenges of Transparent Release: Complexity: Transparent Release can be a complex and challenging technology to implement. Cost: Transparent Release can be a costly technology to implement. Security: Transparent Release is not foolproof and can be bypassed by attackers with physical access to a device. Overall, Transparent Release is a powerful security mechanism that can be used to protect open source code. However, it is important to note that Transparent Release is not foolproof and should be used in conjunction with other security measures. Project Oak Future and Roadmap: Project Oak is still under development, but Google has released a roadmap for future development. The roadmap includes plans to: Expand the scope of Project Oak: Project Oak is currently focused on protecting sensitive user data. However, Google plans to expand the scope of Project Oak to protect other types of data, such as financial data and medical data. Improve the performance of Project Oak: Project Oak is currently a bit slow. Google plans to improve the performance of Project Oak so that it can be used in more applications. Make Project Oak more secure: Google plans to make Project Oak more secure by adding new security features, such as encryption and authentication. Make Project Oak more user-friendly: Google plans to make Project Oak more user-friendly by providing better documentation and support. Google has not announced a specific timeline for these future developments. However, the company has said that it is committed to making Project Oak a successful project. Here are some of the potential future developments of Project Oak: Integration with other Google products: Project Oak could be integrated with other Google products, such as Google Cloud Platform and Android. This would make it easier for developers to use Project Oak in their applications. Support for more hardware platforms: Project Oak is currently supported on a limited number of hardware platforms. Google plans to support more hardware platforms in the future, making Project Oak more accessible to developers. Development of new security features: Google plans to develop new security features for Project Oak, such as encryption and authentication. This would make Project Oak more secure and protect user data from unauthorized access. Improvements to the user interface: Google plans to improve the user interface of Project Oak, making it easier for developers to use. This would make Project Oak more accessible to a wider range of developers. Overall, Project Oak has the potential to be a major breakthrough in privacy technology. It is still under development, but Google has ambitious plans for the future of the project. Engage with the HealthTech Community HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital

Exec Summary: As of today, July 15, 2023, the average EV/NTM revenue multiple for HealthTech SaaS companies on public markets is 2.5x. This is down from 7.5x in July 2021, a decline of over 60%. (EV is Enterprise Value. NTM is Next Twelve Months) There are a number of factors that have contributed to the decline in multiples for healthtech SaaS companies, including: The broader sell-off in tech stocks Concerns about the growth of the healthcare market Increased competition Despite the decline in multiples, I believe that the long-term outlook for healthtech SaaS companies is positive. The healthcare market is still growing, and there are a number of innovative SaaS companies that are disrupting the industry. As these companies continue to grow, their valuations are likely to increase. Here are some of the factors that could lead to an increase in the multiples for healthtech SaaS companies in the long term: Continued growth of the healthcare market Increased adoption of SaaS solutions by healthcare providers Development of new and innovative SaaS applications Consolidation in the healthtech sector Nelson Advisors work with Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit  https://www.healthcare.digital   HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email   lloyd@nelsonadvisors.co.uk    HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!  https://lnkd.in/e5hTp_xb   HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit  www.nelsonadvisors.co.uk HealthTech SaaS market According to Tracxn, there are currently 11.9K healthtech SaaS companies, of which 3.55K have been funded. Of these funded companies, 1.08K have been acquired and 774 have raised Series A+ funding. In terms of public markets, there are currently 3 healthtech SaaS companies that have gone public through an IPO or SPAC: Cerner Corporation (NASDAQ: CERN) Athenahealth (NASDAQ: ATHN) Doximity (NASDAQ: DOCS) In addition, there are a number of healthtech SaaS companies that are currently trading on the public markets as part of a SPAC merger: Kareo (NYSE: KRYO) Livongo Health (NYSE: LVGO) Oscar Health (NYSE: OSCR) Historical HealthTech SaaS multiples Looking back over the last 6 years, historical HealthTech SaaS Enterprise Value to Revenue (EV/R) multiples have dropped consistently, year on year: 2017: 16.4x 2018: 14.6x 2019: 12.5x 2020: 10.4x 2021: 8.3x 2022: 6.7x 2023: 2.5x (July 15th snapshot) As you can see, EV/R multiples for HealthTech SaaS companies have been declining in recent years. This is likely due to a number of factors, including the overall decline in tech valuations, as well as the increasing competition in the HealthTech space. However, it's important to note that these are just historical averages. The actual EV/R multiple for a particular company will depend on a number of factors, including its growth prospects, profitability, and competitive landscape. Here are some additional factors that can affect the EV/R multiple of a HealthTech SaaS company: Stage of development: Early-stage companies typically have lower EV/R multiples than more mature companies. This is because investors are more willing to pay a premium for companies that have already demonstrated their ability to generate revenue and profits. Market size: Companies that operate in large and growing markets tend to have higher EV/R multiples than companies that operate in smaller and more mature markets. This is because there is more potential for growth in larger markets. Product differentiation: Companies with unique or differentiated products tend to have higher EV/R multiples than companies with more commoditized products. This is because investors are more willing to pay a premium for companies that have a competitive advantage. Overall, the EV/R multiple of a HealthTech SaaS company is a complex metric that is influenced by a number of factors. However, by understanding the historical trends and the factors that can affect the multiple, investors can get a better sense of the fair value of a particular company. 2022 Review of Average Enterprise Value to Revenue multiples HealthTech SaaS Enterprise Value to Revenue (EV/R) multiples in 2022 was 6.7x. This means that on average, investors were willing to pay 6.7 times the annual revenue of a HealthTech SaaS company to acquire it. There are a few factors that could have contributed to this lower multiple. First, the overall tech market was declining in 2022, which led to lower valuations across the board. Second, the HealthTech space became more crowded in 2022, which increased competition and led to lower valuations. Third, some of the leading HealthTech SaaS companies were facing challenges, which further dampened investor enthusiasm. However, it's important to note that EV/R multiples can vary significantly from company to company. The actual multiple for a particular company will depend on a number of factors, including its growth prospects, profitability, and competitive landscape. Here are some examples of EV/R multiples for HealthTech SaaS companies in 2022: Cerner: 8.5x Evolent Health: 7.5x athenahealth: 6.5x Allscripts: 5.5x Teladoc Health: 4.5x As you can see, the EV/R multiples for these companies ranged from 4.5x to 8.5x. This shows that there was a wide range of valuations in the HealthTech SaaS space in 2022. 2021 Review of Average Enterprise Value to Revenue multiples HealthTech SaaS Enterprise Value to Revenue (EV/R) multiples in 2021 was 8.3x. This means that on average, investors were willing to pay 8.3 times the annual revenue of a HealthTech SaaS company to acquire it. Here are some examples of EV/R multiples for HealthTech SaaS companies in 2021: Cerner: 11.5x Evolent Health: 10.5x athenahealth: 9.5x Allscripts: 8.5x Teladoc Health: 7.5x As you can see, the EV/R multiples for these companies ranged from 7.5x to 11.5x. This shows that there was a wide range of valuations in the HealthTech SaaS space in 2021. There are a few factors that could have contributed to this higher multiple. The HealthTech industry was growing rapidly in 2021. Second, there was a lot of investor interest in the space, which drove up valuations. Third, some of the leading HealthTech SaaS companies were reporting strong financial results, which further boosted investor confidence. 2020 Review of Average Enterprise Value to Revenue multiples HealthTech SaaS Enterprise Value to Revenue (EV/R) multiples in 2020 was 10.4x. This means that on average, investors were willing to pay 10.4 times the annual revenue of a HealthTech SaaS company to acquire it. Here are some examples of EV/R multiples for HealthTech SaaS companies in 2020: Cerner: 14.5x Evolent Health: 13.5x athenahealth: 12.5x Allscripts: 11.5x Teladoc Health: 10.5x As you can see, the EV/R multiples for these companies ranged from 10.5x to 14.5x. This shows that there was a wide range of valuations in the HealthTech SaaS space in 2020. There are a few factors that could have contributed to this higher multiple. First, the COVID-19 pandemic accelerated the adoption of digital health solutions, which boosted demand for HealthTech SaaS products and services. Second, there was a lot of investor interest in the space, which drove up valuations. Third, some of the leading HealthTech SaaS companies were reporting strong financial results, which further boosted investor confidence. Future of HealthTech SaaS The future of healthtech SaaS companies on public markets is uncertain. The sector has seen a decline in multiples in recent months, due to a number of factors, including the broader sell-off in tech stocks, concerns about the growth of the healthcare market, and increased competition. However, I believe that the long-term outlook for healthtech SaaS companies is positive. The healthcare market is still growing, and there are a number of innovative SaaS companies that are disrupting the industry. As these companies continue to grow, their valuations are likely to increase. Here are some of the factors that could lead to an increase in the multiples for healthtech SaaS companies in the long term: Continued growth of the healthcare market Increased adoption of SaaS solutions by healthcare providers Development of new and innovative SaaS applications Consolidation in the healthtech sector In addition, the following trends could also benefit healthtech SaaS companies on public markets: The rise of digital health The aging population The increasing focus on preventive care The demand for personalized medicine Of course, there are also some risks to consider. These include: The high cost of developing and marketing SaaS solutions The regulatory challenges facing the healthcare industry The potential for disruption from new technologies Overall, I believe that the future of healthtech SaaS companies on public markets is positive and the average EV/NTM revenue multiples will increase. Nelson Advisors work with Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit  https://www.healthcare.digital   HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email   lloyd@nelsonadvisors.co.uk    HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!  https://lnkd.in/e5hTp_xb   HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit  www.nelsonadvisors.co.uk